Is translocation of bacteria and endotoxin from the gastrointestinal tract a source of sepsis in critically ill patients?
1995; Wiley; Volume: 39; Issue: s105 Linguagem: Inglês
10.1111/j.1399-6576.1995.tb04260.x
ISSN1399-6576
Autores Tópico(s)Respiratory Support and Mechanisms
ResumoActa Anaesthesiologica ScandinavicaVolume 39, Issue s105 p. 11-19 Is translocation of bacteria and endotoxin from the gastrointestinal tract a source of sepsis in critically ill patients? GÍIASLI H. SIGURDSSON, Corresponding Author GÍIASLI H. SIGURDSSON Department of Anaesthesia and Intensive Care Medicine, University of Berne, Inselspital, Berne, SwitzerlandDepartment of Anaesthesia and Intensive Care Medicine University of Berne, Inselspital CH 3010 Berne SwitzerlandSearch for more papers by this author GÍIASLI H. SIGURDSSON, Corresponding Author GÍIASLI H. SIGURDSSON Department of Anaesthesia and Intensive Care Medicine, University of Berne, Inselspital, Berne, SwitzerlandDepartment of Anaesthesia and Intensive Care Medicine University of Berne, Inselspital CH 3010 Berne SwitzerlandSearch for more papers by this author First published: June 1995 https://doi.org/10.1111/j.1399-6576.1995.tb04260.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Carrico C, Meakins J, Marshall J, Fry D, Maier R. Multiple-organ-failure syndrome. Arch Surg 1986: 121: 196–201. 2 Centres for Disease Control. Increases in national hospital discharge survey rates for septicemia - United States, 1979–1987. MMWR 1990: 39: 31–34. 3 Cerra F. Multiple organ failure syndrome. Dis Mon 1992: 38: 843–947. 4 Schlag G, Redl H, Hallström S. The cell in shock: The origin of multiple organ failure. Resuscitation 1991: 21: 137–180. 5 Shoemaker W C, Montgomery E S, Kaplan E, Elwyn D H. Physiologic patterns in surviving and nonsurviving shock patients. Arch Surg 1973: 106: 630–636. 6 Meakins J, Marshall J. The gut as the motor of multiple system organ failure. In: A Marston, E Arnold, eds. Splanchnic ischemia and multiple organ failure. St Louis: CV Mosby Co, 1989: 339–348. 7 Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen E. Regional blood flow and oxygen transport in septic shock. Critical Care Med 1993: 21: 1296–1303. 8 Sigurdsson G. Intensive care management of acute pancreatitis. Dig Surg 1995: in press. 9 Norton L. Does drainage of intra-abdominal pus reverse multiple organ failure? Am J Surg 1985: 149: 347–350. 10 Border J, Hassett J, LaDuca J, Seibel R, Steinberg S, Mills B, Losi P, Border D. The gut origin septic state in blunt multiple trauma (ISS=40) in the ICU. Ann Surg 1987: 206: 427–448. 11 Vincent J, Parquier J, Preiser J, Brimioulee S, Kahn R. Terminal events in the intensive care unit: Review of 258 fatal cases in one year. Critical Care Med 1989: 17: 530–533. 12 Fiddian-Green R. Studies in splanchnic ischemia and multiple organ failure. In: A Marston, E Arnold, eds. Splanchnic ischemia and multiple organ failure. St Louis: CV Mosby Co, 1989: 349–363. 13 Gutierrez G. Regional blood flow and oxygen transport: Implications for the therapy of the septic patient. Critical Care Med 1993: 21: 1263–1264. 14 Landow L, Andersen L. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994: 38: 626–639. 15 Sigurdsson G H, Christenson J T, El-Rakshy M B, Sadek S. Intestinal platelet trapping after traumatic and septic shock. An early sign of sepsis and multiorgan failure in critically ill patients? Critical Care Med 1992: 20: 458–467. 16 Sagar P, Sedman P, Mitchell C, MacFie J. The clinical significance of gut translocation of bacteria. In: M Rennie, eds. Intensive Care Britain 1994. London: Greycoat Publishing, 1994: 95–99. 17 Deitch E, Winterton J, Berg R. The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg 1987: 205: 681–892. 18 Berg R, Wommack E, Deitch E. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 1988: 123: 1359–1364. 19 Berg R D. Bacterial translocation from the gastrointestinal tract. J Med 1992: 23: 217–244. 20 Redmond H P, Shou J, Kelly C J, Leon P, Daly J M. Protein-calorie malnutrition impairs host defence against Candida albicans. J Surg Res 1991: 50: 552–559. 21 Alexander J. Barrier function of the intestine: Role of immunonutrition. In: J-L Vincent, eds. Yearbook of intensive care and emergency medicine 1995. Berlin: Springer-Verlag, 1995: 676–683. 22 Michel K, Rombeau J. The impact of critical illness on the gastrointestinal tract. In: J-L Vincent, eds. Yearbook of intensive care and emergency medicine 1995. Berlin: Springer-Verlag, 1995: 663–675. 23 van Leeuwen P A, Boermeester M A, Houdijk A P, Ferwerda C C, Cuesta M A, Meyer S, Wesdorp R I. Clinical significance of translocation. Gut 1994: 35(1 Suppl): S28–S34. 24 Inoue Y, Grant J, Snyder P. Effect of glutamine-supplemented total parenteral nutrition on recovery of the small intestine after starvation atrophy. JPEN 1993: 17: 165–170. 25 Illig K, Ryan C, Hardy D, Rhodes J, Locke W, Sax H. Total parenteral nutrition-induced changes in gut mucosal function: Atrophy alone is not the issue. Surgery 1992: 112: 631–637. 26 Atkinson S, Bihari D. The benefits of enteral feeding in the critically ill patient. Current Opinion Anaesthesiol 1994: 7: 131–135. 27 Okuma T, Kaneko H, Chen K, Ogawa N, Torigoe Y, Miyauchi Y, Tosaka M. Total parenteral nutrition supplemented with L-alanyl-L-glutamine and gut structure and protein metabolism in septic rats. Nutrition 1994: 10: 241–245. 28 Pappo I, Polacheck I, Zmora O, Feigin E, Freund H R. Altered gut barrier function to Candida during parenteral nutrition. Nutrition 1994: 10: 151–154. 29 Hoffman W, Natanson C. Endotoxin in septic shock. Anesth Analg 1993: 77: 613–624. 30 Sigurdsson G H, Youssef H A F. Effects of pentoxifylline on hemodynamics, gas-exchange and multiple organ platelet sequestration in endotoxic shock. Acta Anaesthesiol Scand 1993: 37: 396–403. 31 Sigurdsson G H, Youssef H A F, Banic A. Effects of ketoprofen on respiratory and circulatory changes in endotoxic shock. Intensive Care Med 1993: 19: 333–339. 32 Sigurdsson G H, Youssef H A E, Owunnwanne A. Effects of two different inhibitors of the arachidonic acid metabolism on platelet sequestration in endotoxic shock. Res Exp Med 1994: 195: 287–295. 33 Sigurdsson G H, Youssef H A F. Amelioration of respiratory and circulatory changes in established endotoxic shock by ketoprofen, a dual inhibitor of the arachidonic acid metabolism. Acta Anesthesiol Scand 1994: 38: 33–39. 34 Deitch E A. Bacterial translocation: the influence of dietary variables. Gut 1994: 35 (1 Suppl): S23–S27. 35 Deitch E A, Kemper A C, Specian R D, Berg R D. A study of the relationship among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 1992: 32: 141–147. 36 Sigurdsson G H, Youssef H, Stephen S. Multiple organ platelet sequestration, hemodynamics and gas exchange in endotoxin shock and the effects of aspirin-terbutaline treatment. Am J Physiol Imaging 1992: 7: 66–72. 37 Sigurdsson G, Youssef H, Al-Mousawi M, Khourshid M, Christenson J. Effects of the beta-2 receptor agonist terbutaline on hemodynamics and gas exchange in endotoxin shock. Acta Chir Scand 1989: 155: 369–375. 38 Sigurdsson G H, Christenson T, Al-Mousawi M, Owunnwanne A. The use of Indium-111 oxine to study pulmonary and hepatic sequestration of leukocytes in endotoxin shock and the effects of the beta-2 receptor agonist, terbutaline. Am J Physiol Imaging 1989: 4: 136–142. 39 Sigurdsson G, Christenson J. Influence of terbutaline on endotoxin induced lung injury. Circ Shock 1988: 25: 153–163. 40 Fink M, Antonson J, Wang H, Rothschild H. Increased intestinal permeability in endotoxic pigs: Mesenteric hypoperfusion as an etiologic factor. Arch Surg 1991: 126: 211–218. 41 Fink M, Cohn S, Lee P. Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: Evidence of gut ischemia in a normodynamic model of septic shock. Critical Care Med 1989: 17: 641–646. 42 Nelson D, Samsel R, Wood L, Schumacker P. Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia. J Appl Physiol 1988: 64: 2410–2419. 43 Bursztein-De Myttenaere S-A, Singer P. Hepatic and splanchnic response in multiorgan failure. Anesth Clin N Am 1988: 6: 185–202. 44 Fry D. Multiple system organ failure. Surg Clin N Am 1988: 68: 107–122. 45 McMenamy R, Birkhanan R, Birkhanan GO, Reed R, Rumph C, Vaidyanath N, Yu L, Cerra F, Sorkenss R, Border J. Multiple systems organ failure: I. The basal state. J Trauma 1981: 21: 99–114. 46 Youssef H A E, Sigurdsson G H, Owunnwanne A. Dynamic study of plasma protein leakage in multiple organs during endotoxic shock as monitored with a double isotope technique. Med Principles Practice 1993: 3: 147–155. 47 Christenson J T, Sigurdsson G H, Mousawi M, Owunnwanne A. Use of Indium-Ill Oxine to study the effects of terbutaline on pulmonary and hepatic platelet sequestration in endotoxin shock. Am J Physiol Imaging 1987: 2: 186–191. 48 Matuschak G, Lechner A. Hepatic regulation of systemic host defence and its derangements in multiple systems organ dysfunction and failure. In: G Matuschak, eds. Multiple systems organ failure. Hepatic regulation of systemic host defence. New York: Marcel Dekker, 1993: 1–38. 49 Runkel N S, Rodrigues L F, LaRocco M T, Moody F G. Mechanisms of pancreatic infection in acute pancreatitis in opossums. Curr Surg 1990: 47: 460–462. 50 Blair P, Rowlands B, Lowry K, Webb H, Armstrong P, Smilje J. Selective decontamination of the digestive tract. A stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991: 110: 303–310. 51 McClelland P, Murray A, Yaqoob M, Van Sane H, Bone J, Mostafa S. Prevention of bacterial infection and sepsis in acute severe pancreatitis. Ann R Coll Surg Engl 1992: 74: 329–334. 52 Rush B, Sori A, Murphy T, Smith S, Flanagan J, Machiedo G. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg 1988: 207: 549–554. 53 Koziol J, Rush B J, Smith S, Machiedo G. Occurrence of bacteremia during and after hemorrhagic shock. J Trauma 1988: 28: 10–16. 54 Deitch E, Bridges W, Baker J, Ma J-W, Ma L, Grisham M, Granger N, Specian R, Berg R. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxydase inhibition or inactivation. Surgery 1988: 104: 191–198. 55 Morales J, Kibsey P, Thomas P, Poznansky M, Hamilton S. The effects of ischemia and ischemiareperfusion on bacterial translocation, lipid peroxidation, and gut histology: Studies on hemorrhagic shock in pigs. J Trauma 1992: 33: 221–227. 56 van Deventer S, Gouma D. Bacterial translocation and endotoxin transmigration in intestinal ischaemia and reperfusion. Current Opinion Anaesthesiol 1994: 7: 126–130. 57 Hebra A, Hong J, McGowan K L, Smith C, McKernan M L, Ross A Jr. Bacterial translocation in mesenteric ischemia-reperfusion injury: is dysfunctional motility the link? J Pediatr Surg 1994: 29: 280–285. 58 Zapata-Sirvent R L, Marzullo M V, Pinate S, del M P, Urbina A, Larocca A, Antequera R, Guzman M, Pifano E. [Bacterial translocation in a model of intestinal obstruction. II. Bacteriological study and role of cellular immunity]. G E N 1991: 45: 273–280. 59 Ding J W, Anderson R, Soltesz V, Willen R, Bengmark S. Obstructive jaundice impairs reticuloen dothelial function and promotes bacterial translocation in the rat. J Surg Res 1994: 57: 238–245. 60 Browne B J, Johnson C P, Edmiston C E, Hlava M A, Moore G H, Roza A M, Telford G L, Adams M B. Small bowel transplantation promotes bacterial overgrowth and translocation. J Surg Res 1991: 51: 512–517. 61 Runkel N S, Moody F G, Smith G S, Rodriguez L F, Chen Y, Larocco M T, Miller T A. Alterations in rat intestinal transit by morphine promote bacterial translocation. Dig Dis Sci 1993: 38: 1530–1536. 62 Baron P, Traber L D, Traber D L, Nguyen T, Hollyoak M, Heggers J P, Herndon D N. Gut failure and translocation following burn and sepsis. J Surg Res 1994: 57: 197–204. 63 Deitch E, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 1987: 122: 185–190. 64 Deitch E, Winterton J, Berg R. Thermal injury promotes bacterial translocation from the gastrointestinal tract in mice with impaired T-cell mediated immunity. Arch Surg 1986: 121: 97–111. 65 Lelli JL, Jr., Drongowski RA, Coran A G, Abrams G D. Hypoxia-induced bacterial translocation in the puppy. J Pediatr Surg 1992: 27: 974–981. 66 Zaloga G P, Roberts P, Black K W, Prielipp R. Gut bacterial translocation/dissemination explains the increased mortality produced by parenteral nutrition following methotrexate. Circ Shock 1993: 39: 263–268. 67 Deitch E, Winterton J, Berg R. The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg 1987: 205: 681–686. 68 Alverdy J, Chi H, Sheldon G. The effect of parenteral nutrition on gastrointestinal immunity, the importance of enteral stimulation. Ann Surg 1985: 202: 681–684. 69 Ford E G, Baisden C E, Matteson M L, Picone A L. Sepsis after coronary bypass grafting: evidence for loss of the gut mucosal barrier. Ann Thorac Surg 1991: 52: 514–517. 70 Baue A E. The role of the gut in the development of multiple organ dysfunction in Cardiothoracic patients. Ann Thorac Surg 1993: 55: 822–829. 71 Saadia R, Schein M, MacFarlane C, Boffard K. Gut barrier function and the surgeon. Br J Surg 1990: 77: 487–492. 72 Sedman P C, MacFie J, Sagar P, Mitchell C J, May J, Mancey-Jones B, Johnstone D. The prevalence of gut translocation in humans. Gastroenterology 1994: 107: 643–649. 73 Ledingham I, Eastaway A, McKay I, Alcock S, McDonald D, Ramsay G. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988: i: 786–790. 74 Mythen M, Webb A. The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction. Intensive Care Med 1994: 20: 203–209. 75 Schoenberg M, Berger H. Reperfusion injury after intestinal ischemia. Critical Care Med 1993: 21: 1376–1386. 76 Abraham E. Host defence abnormalities after hemorrhage, trauma, and burns. Critical Care Med 1989: 17: 934–939. 77 Haglund U. Systemic mediators released from the gut in critical illness. Critical Care Med 1993: 21(2 Suppl): S15–S18. 78 Ruokonen E, Takala J, Kari A. Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Critical Care Med 1993: 21: 1304–1311. 79 Takala J. Splanchnic perfusion in shock. Intensive Care Med 1994: 20: 403–404. 80 Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Achiavi E, Jorge M Pusajo J, Klein F, San Roman E, Dorman B Shottlender J, Giniger R. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992: 339: 195–199. 81 Senkal M, Kemen M, Homann H-H, Eickhoff U Baier J, Zumtobel V. Modulation of postoperative immune response by enteral nutrition with arginine RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995: 161: 115–122. 82 Nord C, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984: 76: 99–105. 83 Munster A M, Smith-Meek M, Dickerson C Winchurch RA. Translocation. Incidental phenomenon or true pathology? Ann Surg 1993: 218: 321–326. 84 Bach A, Frey A, Lutz O. Clinical and experimenta effects of medium-chain-triglyceride-based fat emulsions. Clin Nutrition 1989: 8: 223–234. 85 Heyland D, Cook D, Guyatt G. Enteral nutrition in the critically ill patient: a critical review of the evidence. Intensive Care Med 1993: 19: 435–442. 86 Jeevanandam M, Shamos R, Petersen S. Substrate efficacy in early nutrition support of critically ill multiple trauma victims. JPEN 1992: 16: 511–520. 87 Kaminski MV, Jr., Blumeyer TJ. Metabolic and nutritional support of the intensive care patient. Ascending the learning curve. Critical Care Clin 1993: 9: 363–376. 88 Pscheidl E M, Wan J M, Blackburn G L, Bistrian B R, Istfan N W. Influence of omega-3 fatty acids on splanchnic blood flow and lactate metabolism in an endotoxemic rat model. Metabolism 1992: 41: 698–705. 89 Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994: 35(1 Suppl): S35–S38. 90 Gennari R, Alexander J W, Gianotti L, Eaves-Pyles T. Hartmann S. Granulocyte macrophage colony-stimulating factor improves survival in two models of gutderived sepsis by improving gut barrier function and modulating bacterial clearance. Ann Surg 1994: 220: 68–76. 91 Gennari R, Alexander J W, Eaves-Pyles T. IFN-gamma decreases translocation and improves survival following transfusion and thermal injury. J Surg Res 1994: 56: 530–536. 92 Gianotti L, Alexander J W, Pyles T, Fukushima R. Arginine-supplemented diets improve survival in gutderived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 1993: 217: 644–653. 93 Bower R, Cerra F, Bershadsky B, Licari J, Hoyt D, Jensen G, Van Buren C, Rothkopf M, Daly J, Adelsberg B. Early enteral administration of a formula (Impact®) supplemented with arginine, nucleotides and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized, clinical trial. Critical Care Med 1995: 23: 436–449. Citing Literature Volume39, Issues105June 1995Pages 11-19 ReferencesRelatedInformation
Referência(s)